Windtree Therapeutics Inc (WINT)
0.5093
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.5091
0.00 (0.00%)
Pre-Market: 08:16
Windtree Therapeutics Max Drawdown (5Y): 99.99% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.99% |
| September 30, 2024 | 99.98% |
| August 31, 2024 | 99.98% |
| July 31, 2024 | 99.98% |
| June 30, 2024 | 99.98% |
| May 31, 2024 | 99.97% |
| April 30, 2024 | 99.96% |
| March 31, 2024 | 99.96% |
| February 29, 2024 | 99.96% |
| January 31, 2024 | 99.94% |
| December 31, 2023 | 99.91% |
| November 30, 2023 | 99.89% |
| October 31, 2023 | 99.89% |
| September 30, 2023 | 99.89% |
| August 31, 2023 | 99.87% |
| July 31, 2023 | 99.85% |
| June 30, 2023 | 99.85% |
| May 31, 2023 | 99.85% |
| April 30, 2023 | 99.80% |
| March 31, 2023 | 99.67% |
| February 28, 2023 | 99.67% |
| January 31, 2023 | 99.67% |
| December 31, 2022 | 99.67% |
| November 30, 2022 | 99.67% |
| October 31, 2022 | 99.67% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.67% |
| August 31, 2022 | 99.67% |
| July 31, 2022 | 99.67% |
| June 30, 2022 | 99.67% |
| May 31, 2022 | 99.67% |
| April 30, 2022 | 99.67% |
| March 31, 2022 | 99.67% |
| February 28, 2022 | 99.67% |
| January 31, 2022 | 99.67% |
| December 31, 2021 | 99.67% |
| November 30, 2021 | 99.67% |
| October 31, 2021 | 99.67% |
| September 30, 2021 | 99.67% |
| August 31, 2021 | 99.67% |
| July 31, 2021 | 99.67% |
| June 30, 2021 | 99.67% |
| May 31, 2021 | 99.67% |
| April 30, 2021 | 99.67% |
| March 31, 2021 | 99.67% |
| February 28, 2021 | 99.67% |
| January 31, 2021 | 99.67% |
| December 31, 2020 | 99.67% |
| November 30, 2020 | 99.67% |
| October 31, 2020 | 99.67% |
| September 30, 2020 | 99.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.67%
Minimum
Nov 2019
99.99%
Maximum
Oct 2024
99.75%
Average
99.67%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| ANI Pharmaceuticals Inc | 72.96% |
| AIM ImmunoTech Inc | 99.76% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.38% |
| Armata Pharmaceuticals Inc | 99.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -95.35 |
| Beta (5Y) | 0.6422 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 122.7% |
| Historical Sharpe Ratio (5Y) | -0.7094 |
| Historical Sortino (5Y) | -1.383 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 60.57% |